Kestra Medical Technologies, Ltd. (KMTS) Stock Overview
Explore Kestra Medical Technologies, Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Kestra Medical Technologies, Ltd. (KMTS)
Key Financials
Key Financials
Market Cap
1.5B
P/E Ratio
-9.53
EPS (TTM)
$-2.65
ROE
-0.64%
KMTS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Kestra Medical Technologies, Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of KMTS on the NASDAQ shows an RSI of 46.89, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $30.69 for the NASDAQ listing.
Key metrics behind Kestra Medical Technologies, Ltd.'s NASDAQ-traded stock include a P/E ratio of -9.53 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of KMTS on the NASDAQ.